Arrhythmia, Heart Rate Variability, and Antiepileptic Drugs

Summary: This article reviews the clinical evidence for cardiac arrhythmias and alterations in heart rate variability (HRV) induced by antiepileptic drugs (AEDs). The medical literature was searched for cases with documented arrhythmias induced by AEDs at therapeutic doses, for systematic studies of the prevalence of arrhythmias related to AED therapy, and for studies on HRV in relation to AED treatment. Phenytoin has been associated predominantly with bradyarrhythmias, some of which were fatal. This has occurred almost exclusively with i.v. administration of the drug. Several reports demonstrate car‐bamazepine's depressant effects on the cardiac conduction system. This has occurred mainly in the elderly or in otherwise predisposed patients. There were no reports of arrhythmias induced by other AEDs. Although information on HRV is scarce, treatment with carbamazepine appears to be associated with a decreased HRV. AED‐induced cardiac arrhythmias are rare and occur mainly in patient populations different from those with a high incidence of sudden unexpected death. Further studies of HRV and AEDs are needed.

[1]  E. Shanbrom,et al.  Immunodiffusion techniques in clinical medicine. I. Immunoelectrophoresis. , 1967, JAMA.

[2]  J. Marx,et al.  Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage. , 1983, JAMA.

[3]  F. Elliott,et al.  Carbamazepine for phantom-limb phenomena. , 1976, The New England journal of medicine.

[4]  R. Mutani,et al.  Cardiac side effects of phenytoin and carbamazepine. A dose-related phenomenon? , 1985, Archives of neurology.

[5]  Orrin Devinsky,et al.  Interictal Autonomic Nervous System Function in Patients with Epilepsy , 1994, Epilepsia.

[6]  S. Quint,et al.  Monitoring heart period variability changes during seizures. I. Methods , 1990 .

[7]  C. Loeb,et al.  Carbamazepine and cardiac conduction disturbances , 1987, Annals of neurology.

[8]  T. Tomson,et al.  Heart rate variability in patients with epilepsy 1 Presented in part at the 2nd European Congress of Epileptology, The Hague, September, 1996. 1 , 1998, Epilepsy Research.

[9]  J. Rice,et al.  Carbamazepine therapy complicated by nodal bradycardia and water intoxication. , 1979, Australian and New Zealand journal of medicine.

[10]  M. Manfredi,et al.  Sino-atrial block provoked by carbamazepine. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[11]  S. Morooka,et al.  Carbamazepine-induced bradycardia-tachycardia syndrome with pharmacological analysis and concurrent ECG monitoring. , 1990, Journal of electrocardiology.

[12]  C. Martínez,et al.  Fatal ventricular fibrillation following intravenous sodium diphenylhydantoin therapy. , 1967, JAMA.

[13]  J. Engel,et al.  Interictal heart rate patterns in partial seizure disorders , 1993, Neurology.

[14]  M. Fox.  THE REVERSIBILITY OF IRREVERSIBLE SHOCK. , 1963, Lancet.

[15]  ADVERSE DRUG REACTIONS ADVISORY COMMITTEE , 1980 .

[16]  S. Ladefoged,et al.  Cardiac conduction disturbances during carbamazepine therapy , 1983, Acta neurologica Scandinavica.

[17]  H. Neufeld,et al.  [Diphenylhydantoin in cardiac arrhythmias]. , 1970, Harefuah.

[18]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[19]  R. E. Ganz,et al.  Central cardio-autonomic disorganization in interictal states of epilepsy detected by phase space analysis. , 1994, The International journal of neuroscience.

[20]  S. Zoneraich,et al.  Sudden death following intravenous sodium diphenylhydantoin. , 1976, American heart journal.

[21]  B. Beermann,et al.  Advanced heart block aggravated by carbamazepine. , 1975, British heart journal.

[22]  P. Schraeder,et al.  Paroxysmal autonomic dysfunction, epileptogenic activity and sudden death. , 1989, Epilepsy research.

[23]  Voigt Gc.  Death following intravenous sodium diphenylhydantoin (dilantin). , 1968 .

[24]  T. Tomson,et al.  Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system. , 1991, American heart journal.

[25]  A. Unger,et al.  Fatalities following intravenous use of sodium diphenylhydantoin for cardiac arrhythmias. Report of two cases. , 1967, JAMA.

[26]  H. Kutt,et al.  Intravenous diphenylhydantoin in treatment of acute repetitive seizures , 1968, Neurology.

[27]  I. Klausen,et al.  [Carbamazepine and heart conduction disorders]. , 1988, Ugeskrift for laeger.

[28]  L. Herzberg.  CARBAMAZEPINE AND BRADYCARDIA , 1978, The Lancet.

[29]  A. Moss,et al.  Primidone in the treatment of the long QT syndrome: QT shortening and ventricular arrhythmia suppression. , 1980, Annals of internal medicine.

[30]  Bradley V. Vaughn,et al.  Monitoring heart period variability changes during seizures. II. Diversity and trends , 1996 .

[31]  G. Bousvaros,et al.  Fatal results from diphenylhydantoin administered intravenously. , 1968, JAMA.

[32]  S. Weig,et al.  Carbamazepine‐induced heart block in a child with tuberous sclerosis and cardiac rhabdomyoma: Implications for evaluation and follow‐up , 1993, Annals of neurology.

[33]  Barron Sa.  Cardiac arrhythmias after small iv dose of phenytoin. , 1976 .

[34]  R. Conn.  DIPHENYLHYDANTOIN SODIUM IN CARDIAC ARRHYTHMIAS. , 1965, The New England journal of medicine.

[35]  D. Hamilton.  CARBAMAZEPINE AND HEART BLOCK , 1978, The Lancet.

[36]  S. Stone,et al.  Syncope and sudden unexpected death attributed to carbamazepine in a 20-year-old epileptic. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[37]  T. Tomson,et al.  Carbamazepine induced bradycardia - a problem in general or only in susceptible patients? A 24-h long-term electrocardiogram study , 1992, Epilepsy Research.

[38]  J. Bigger,et al.  Relationship Between the Plasma Level of Diphenylhydantoin Sodium and Its Cardiac Antiarrhythmic Effects , 1968, Circulation.

[39]  P. Schraeder,et al.  Paroxysmal autonomie dysfunction, epileptogenic activity and sudden death , 1989, Epilepsy Research.

[40]  T. Tomson,et al.  Changes in arrhythmia profile and heart rate variability during abrupt withdrawal of antiepileptic drugs. Implications for sudden death , 1997, Seizure.

[41]  J. Karliner,et al.  Ventricular standstill after intravenous diphenylhydantoin. , 1967, American heart journal.

[42]  M. Weir,et al.  The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .

[43]  J. Karliner.  Intravenous diphenylhydantoin sodium (Dilantin) in cardiac arrhythmias. , 1967, Diseases of the chest.